{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T02:36:48Z","timestamp":1768617408371,"version":"3.49.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"DOI":"10.1093\/cid\/ciae231","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T05:40:42Z","timestamp":1715838042000},"page":"i47-i50","source":"Crossref","is-referenced-by-count":1,"title":["The Obstacle is the Way: Finding a Path to Hepatitis C Elimination"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-0600","authenticated-orcid":false,"suffix":"III","given":"Vincent","family":"Lo Re","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]},{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-5696","authenticated-orcid":false,"given":"Jennifer C","family":"Price","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, University of California San Francisco , San Francisco, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine , Cleveland, Ohio ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4143-1950","authenticated-orcid":false,"given":"Norah","family":"Terrault","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastrointestinal and Liver Diseases, University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2136-7763","authenticated-orcid":false,"given":"Debika","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Arohnson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Chicago , Chicago, Illinois ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"2026011609460844500_ciae231-B1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2023.3692","article-title":"A National Hepatitis C Elimination Program in the United States: A historic opportunity","volume":"329","author":"Fleurence","year":"2023","journal-title":"JAMA"},{"key":"2026011609460844500_ciae231-B2","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMra1810477","article-title":"Global elimination of chronic hepatitis","volume":"380","author":"Thomas","year":"2019","journal-title":"N Engl J Med"},{"key":"2026011609460844500_ciae231-B3","author":"American Association for the Study of Liver Diseases\/Infectious Diseases Society of America"},{"key":"2026011609460844500_ciae231-B4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad319","article-title":"Hepatitis C Guidance 2023 Update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","author":"Bhattacharya","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026011609460844500_ciae231-B5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/HEP.0000000000000444","article-title":"The national hepatitis C elimination program\u2014AASLD\u2019s coalition and call to action","volume":"78","author":"American Association for the Study of Liver Diseases","year":"2023","journal-title":"Hepatology"},{"key":"2026011609460844500_ciae231-B6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciad411","article-title":"Estimated prevalence and awareness of hepatitis C virus infection among U.S. adults\u2014National Health and Nutrition Examination Survey, January 2017-March 2020","volume":"77","author":"Lewis","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026011609460844500_ciae231-B7","author":"World Health Organization"},{"key":"2026011609460844500_ciae231-B8","author":"National Academies of Sciences, Engineering, and Medicine","year":"2016"},{"key":"2026011609460844500_ciae231-B9","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"key":"2026011609460844500_ciae231-B10","article-title":"Department of Health and Human Services","author":"U.S"},{"key":"2026011609460844500_ciae231-B11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.30501","article-title":"The hepatitis C virus care continuum: Linkage to hepatitis C virus care and treatment among patients at an urban health network, Philadelphia, PA","volume":"70","author":"Coyle","year":"2019","journal-title":"Hepatology"},{"key":"2026011609460844500_ciae231-B12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/cid\/cix333","article-title":"Geographic disparities in access to syringe services programs among young persons with hepatitis C virus infection in the United States","volume":"65","author":"Canary","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026011609460844500_ciae231-B13","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs","volume":"9","author":"Platt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026011609460844500_ciae231-B14","author":"Centers for Disease Control and Prevention"},{"key":"2026011609460844500_ciae231-B15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/cid\/ciac139","article-title":"Characteristics of persons treated for hepatitis C using national pharmacy claims data, United States, 2014-2020","volume":"75","author":"Teshale","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026011609460844500_ciae231-B16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jiph.2022.11.021","article-title":"Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress","volume":"16","author":"Blach","year":"2023","journal-title":"J Infect Public Health"},{"key":"2026011609460844500_ciae231-B17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac445","article-title":"The hepatitis C care cascade during the direct-acting antiviral era in a United States commercially insured population","volume":"9","author":"Ferrante","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2026011609460844500_ciae231-B18","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2020.1123","article-title":"Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force Recommendation Statement","volume":"323","author":"Owens","year":"2020","journal-title":"JAMA"},{"key":"2026011609460844500_ciae231-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"Ryerson AB. CDC recommendations for hepatitis C screening among adults\u2014 United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2026011609460844500_ciae231-B20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S2468-1253(20)30365-4","article-title":"Hepatitis C elimination among people incarcerated in prisons: Challenges and recommendations for action within a health systems framework","volume":"6","author":"Akiyama","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026011609460844500_ciae231-B21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2019.02.008","article-title":"Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated","volume":"198","author":"Morris","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2026011609460844500_ciae231-B22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.drugalcdep.2018.11.026","article-title":"Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle","volume":"195","author":"Tsui","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2026011609460844500_ciae231-B23","doi-asserted-by":"crossref","first-page":"766","DOI":"10.15585\/mmwr.mm7228a2","article-title":"Updated operational guidance for implementing CDC\u2019s recommendations on testing for hepatitis C virus infection","volume":"72","author":"Cartwright","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026011609460844500_ciae231-B24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy076","article-title":"Absolute insurer denial of direct-acting antiviral therapy for hepatitis C: A national specialty pharmacy cohort study","volume":"5","author":"Gowda","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2026011609460844500_ciae231-B25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.15585\/mmwr.mm7132e1","article-title":"Vital signs: Hepatitis C treatment among insured adults\u2014United States, 2019-2020","volume":"71","author":"Thompson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026011609460844500_ciae231-B26","author":"Center for Health Law and Policy Innovation and National Viral Hepatitis Roundtable"},{"key":"2026011609460844500_ciae231-B27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jhep.2015.06.014","article-title":"Excluding people who use drugs or alcohol from access to hepatitis C treatments\u2014Is this fair, given the available data?","volume":"63","author":"Grebely","year":"2015","journal-title":"J Hepatol"},{"key":"2026011609460844500_ciae231-B28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/jvh.13343","article-title":"Determinants of stigma among patients with hepatitis C virus infection","volume":"27","author":"Saine","year":"2020","journal-title":"J Viral Hepat"},{"key":"2026011609460844500_ciae231-B29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2468-1253(22)00346-6","article-title":"Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: A systematic review and meta-analysis","volume":"8","author":"Trickey","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026011609460844500_ciae231-B30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S2468-1253(18)30002-5","article-title":"Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: A systematic review and metaanalysis","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026011609460844500_ciae231-B31","author":"Gee"},{"key":"2026011609460844500_ciae231-B32","doi-asserted-by":"crossref","first-page":"22146","DOI":"10.7448\/IAS.20.1.22146","article-title":"Elimination of HCV as a public health concern among people who inject drugs by 2030\u2014What will it take to get there?","volume":"20","author":"Grebely","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"2026011609460844500_ciae231-B33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12954-016-0107-0","article-title":"Beyond equipment distribution in Needle and Syringe Programmes: An exploratory analysis of blood-borne virus risk and other measures of client need","volume":"13","author":"Treloar","year":"2016","journal-title":"Harm Reduct J"},{"key":"2026011609460844500_ciae231-B34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12954-020-00399-8","article-title":"They look at us like junkies: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City","volume":"17","author":"Muncan","year":"2020","journal-title":"Harm Reduct J"},{"key":"2026011609460844500_ciae231-B35","doi-asserted-by":"crossref","first-page":"e104515","DOI":"10.1371\/journal.pone.0104515","article-title":"Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions","volume":"9","author":"Palmateer","year":"2014","journal-title":"PLoS One"},{"key":"2026011609460844500_ciae231-B36","author":"National Academies of Sciences, Engineering, and Medicine"},{"key":"2026011609460844500_ciae231-B37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The micro-elimination approach to eliminating hepatitis C: Strategic and operational considerations","volume":"38","author":"Lazarus","year":"2018","journal-title":"Semin Liver Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae231\/57678480\/ciae231.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/Supplement_3\/i47\/66429946\/ciae231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/Supplement_3\/i47\/66429946\/ciae231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:46:17Z","timestamp":1768574777000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/Supplement_3\/i47\/7674204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":37,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2024,5,16]]},"published-print":{"date-parts":[[2026,1,16]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae231","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,15]]},"published":{"date-parts":[[2024,5,16]]}}}